Dietary choline supplementation improves behavioral, histological, and neurochemical outcomes in a rat model of traumatic brain injury

Journal of Neurotrauma

Volumn 25, Issue 8, 2008, Pages 975-983

  Guseva, Maria V ^a,b   Hopkins, Deann M ^a,b   Scheff, Stephen W ^b   Pauly, James R ^a,b  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Acetylcholine; Alpha 7 nAChR; Bungarotoxin; Dietary supplementation; Morris water maze; Neuroprotection; Nicotinic

Indexed keywords

CHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CONTUSION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG POTENCY; ENCEPHALITIS; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; HISTOLOGY; MALE; MAZE TEST; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

ANIMALS; BRAIN INJURIES; CHOLINE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; MALE; MAZE LEARNING; MEMORY; NOOTROPIC AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 50149114171     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2008.0516     Document Type: Article

References (56)

1. Albuquerque, E.X., Pereira, E.F., Braga, M.F., and Alkondon, M. (1998). Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of alpha 7 receptors. J. Physiol. Paris 92, 309-316.
2. Alkondon, M., Pereira, E.F., Cortes, W.S., Maelicke, A., and Albuquerque, E.X. (1997). Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur. J. Neurosci. 9, 2734-2742.
3. Arciniegas, D.B. (2003). The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury. Curr. Psychiatry Rep. 5, 391-399.
4. Banati, R.B., Myers, R., and Kreutzberg, G. W., (1997). PBR ("peripheral benzodiazepine")-binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J. Neurocytol. 26, 77-82.
5. Bazan, N.G., Marcheselli, V.L., and Cole-Edwards, K. (2005). Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann. NY Acad. Sci. 1053, 137-147.
6. Berg, D.K., and Conroy, W.G. (2002). Nicotinic alpha 7 receptors: synaptic options and downstream signaling in neurons. J. Neurobiol. 53, 512-523.
7. Block, M.L., and Hong, J.S. (2005). Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76, 77-98.
8. Blusztajn, J.K. (1998). Choline, a vital amine. Science 281, 794-795.
9. Bramlett, H.M., and Dietrich, W.D. (2004). Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J. Cereb. Blood Flow Metab. 24, 133-150.
10. Buccafusco, J.J., Letchworth, S.R., Bencherif, M., and Lippiello, P.M. (2005). Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. Trends Pharmacol. Sci. 26, 352-360.
11. Cacabelos, R., Caamano, J., Gomez, M.J., Fernandez-Novoa, L., Franco-Maside, A., and Alvarez, X.A. (1996). Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors. Ann. NY Acad. Sci. 777, 399-403.
12. Casellas, P., Galiegue, S., and Basile, A.S. (2002). Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Int. 40, 475-486.
13. Clark, W.M., Warach, S.J., Pettigrew, L.C., Gammans, R.E., and Sabounjian, L.A. (1997). A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology. 49, 671-678.
14. Coutcher, J.B., Cawley, G., and Wecker, L. (1992). Dietary choline supplementation increases the density of nicotine binding sites in rat brain. J. Pharmacol. Exp. Ther. 262, 1128-1132.
15. Dixon, C.E., Bao, J., Bergmann, J.S., and Johnson, K.M. (1994). Traumatic brain injury reduces hippocampal high-affinity [3H]choline uptake but not extracellular choline levels in rats. Neurosci. Lett. 180, 127-130.
16. Dixon, C.E., Bao, J., Johnson, K.M., Yang, K., Whitson, J., Clifton, G.L., and Hayes, R.L. (1995). Basal and scopolamine-evoked release of hippocampal acetylcholine following traumatic brain injury in rats. Neurosci. Lett. 198, 111-114.
17. Dixon, C.E., Bao, J., Long, D.A., and Hayes, R.L. (1996). Reduced evoked release of acetylcholine in the rodent hippocampus following traumatic brain injury. Pharmacol. Biochem. Behav. 53, 679-686.
18. Fayuk, D., and Yakel, J.L. (2004). Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons. Mol. Pharmacol. 66, 658-666.
19. Freedman, R., Adler, L.E., Bickford, P., Byerley, W., Coon, H., Cullum, C.M., Griffith, J.M., Harris, J.G., Leonard, S., Miller, C., et al. (1994). Schizophrenia and nicotinic receptors. Harv. Rev. Psychiatry 2, 179-192.
20. Gaetz, M. (2004). The neurophysiology of brain injury. Clin. Neurophysiol. 115, 4-18.
21. Guan, Z.Z., Zhang, X., Blennow, K., and Nordberg, A. (1999). Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport 10, 1779-1782.
22. Guan, Z.Z., Zhang, X., Ravid, R., and Nordberg, A. (2000). Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J. Neurochem. 74, 237-243.
23. Guseva, M.V., Hopkins, D.M., and Pauly, J.R. (2006). An autoradiographic analysis of rat brain nicotinic receptor plasticity following dietary choline modification. Pharmacol. Biochem. Behav. 84, 26-34.
24. Hall, E.D., Sullivan, P.G., Gibson, T.R., Pavel, K.M., Thompson, B.M., and Scheff, S.W. (2005). Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury. J. Neurotrauma 22, 252-265.
25. Hazell, A.S., Desjardins, P., and Butterworth, R.F. (1999). Chronic exposure of rat primary astrocyte cultures to manganese results in increased binding sites for the "peripheral-type" benzodiazepine receptor ligand 3H-PK 11195. Neurosci. Lett. 271, 5-8.
26. Jonnala, R.R., Graham, J.H., 3rd, Terry, A.V., Jr., Beach, J.W., Young, J.A., and Buccafusco, J.J. (2003). Relative levels of cytoprotection produced by analogs of choline and the role of alpha7-nicotinic acetylcholine receptors. Synapse 47, 262-269.
27. Kihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., Kume, T., and Akaike, A. (2001). Alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem. 276, 13541-13546.
28. Kuhlmann, A.C., and Guilarte, T.R. (1999). Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity. Toxicol. Sci. 48, 107-116.
29. Leon-Carrion, J., Dominguez-Roldan, J.M., Murillo-Cabezas, F., del Rosario Dominguez-Morales, M., and Munoz-Sanchez, M.A. (2000). The role of citicholine in neuropsychological training after traumatic brain injury. NeuroRehabilitation 14, 33-40.
30. Leonard, J.R., Maris, D.O., and Grady, M.S. (1994). Fluid percussion injury causes loss of forebrain choline acetyltransferase and nerve growth factor receptor immunoreactive cells in the rat. J. Neurotrauma 11, 379-392.
31. Levin, E.D., McClernon, F.J., and Rezvani, A.H. (2006). Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl.) 184, 523-539.
32. Marks, M.J., Stitzel, J.A., Romm, E., Wehner, J.M., and Collins, A.C. (1986). Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungaro-toxin. Mol. Pharmacol. 30, 427-436.
33. Marrero, M.B., Papke, R.L., Bhatti, B.S., Shaw, S., and Bencherif, M. (2004). The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[ 3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase. J. Pharmacol. Exp. Ther. 309, 16-27.
34. McIntosh, T.K., Smith, D.H., Meaney, D.F., Kotapka, M.J., Gennarelli, T.A., and Graham, D.I. (1996). Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab. Invest. 74, 315-342.
35. Morley, B.J., Robinson, G.R., Brown, G.B., Kemp, G.E., and Bradley, R.J. (1977). Effects of dietary choline on nicotinic acetylcholine receptors in brain. Nature 266, 848-850.
36. Mulholland, P.J., Self, R.L., Harris, B.R., Littleton, J.M., and Prendergast, M.A. (2004). Choline exposure reduces potentiation of N-methyl-D-aspartate toxicity by corticosterone in the developing hippocampus. Brain Res. Dev. Brain Res. 153, 203-211.
37. Murdoch, I., Perry, E.K., Court, J.A., Graham, D.I., and Dewar, D. (1998). Cortical cholinergic dysfunction after human head injury. J. Neurotrauma 15, 295-305.
38. 3H]PK 11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex. Neurosci. Lett. 133, 20-24.
39. Nott, A., and Levin, E.D. (2006). Dorsal hippocampal alpha7 and alpha4beta2 nicotinic receptors and memory. Brain Res. 1081, 72-78.
40. Park, C.H., Carboni, E., Wood, P.L., and Gee, K.W. (1996). Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line. Glia 16, 65-70.
41. Parnetti, L., Mignini, F., Tomassoni, D., Traini, E., and Amenta, F. (2007). Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation? J. Neurol. Sci. 257, 264-269.
42. 3H]Epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. J. Pharmacol. Exp. Ther. 275, 1030-1034.
43. Rinne, J.O., Myllykyla, T., Lonnberg, P., and Marjamaki, P. (1991). A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res. 547, 167-170.
44. Saija, A., Hayes, R.L., Lyeth, B.G., Dixon, C.E., Yamamoto, T., and Robinson, S.E. (1988). The effect of concussive head injury on central cholinergic neurons. Brain Res. 452, 303-311.
45. Scheff, S.W., and Sullivan, P.G. (1999). Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. J. Neurotrauma 16, 783-792.
46. Shytle, R.D., Mori, T., Townsend, K., Vendrame, M., Sun, N., Zeng, J., Ehrhart, J., Silver, A.A., Sanberg, P.R., and Tan, J. (2004). Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J. Neurochem. 89, 337-343.
47. Sparks, J.A., and Pauly, J.R. (1999). Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice. Psychopharmacology (Berl.) 141, 145-153.
48. Starkstein, S.E., and Jorge, R. (2005). Dementia after traumatic brain injury. Int. Psychogeriatr. 17, Suppl 1, S93-S107.
49. Thurman, D.J., Alverson, C., Dunn, K.A., Guerrero, J., and Sniezek, J.E. (1999). Traumatic brain injury in the United States: a public health perspective. J. Head Trauma Rehabil. 14, 602-615.
50. Town, T., Nikolic, V., and Tan, J. (2005). The microglial "activation" continuum: from innate to adaptive responses. J. Neuroinflamm. 2, 24.
51. Tribollet, E., Bertrand, D., Marguerat, A., and Raggenbass, M. (2004). Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience 124, 405-420.
52. Van Kampen, M., Selbach, K., Schneider, R., Schiegel, E., Boess, F., and Schreiber, R. (2004). AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors. Psychopharmacology (Berl.) 172, 375-383.
53. Verbois, S.L., Scheff, S.W., and Pauly, J.R. (2003). Chronic nicotine treatment attenuates alpha 7 nicotinic receptor deficits following traumatic brain injury. Neuropharmacology 44, 224-233.
54. Verbois, S.L., Sullivan, P.G., Scheff, S.W., and Pauly, J.R. (2000). Traumatic brain injury reduces hippocampal alpha7 nicotinic cholinergic receptor binding. J. Neurotrauma 17, 1001-1011.
55. Wang, H., Yu, M., Ochani, M., Amella, C.A., Tanovic, M., Susarla, S., Li, J.H., Wang, H., Yang, H., Ulloa, L., Al-Abed, Y., Czura, C.J., and Tracey, K.J. (2003). Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421, 384-388.
56. Zeisel, S.H., and Niculescu, M.D. (2006). Perinatal choline influences brain structure and function. Nutr. Rev. 64, 197-203.